Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.

[1]  A. Paller,et al.  Topically applied imiquimod inhibits vascular tumor growth in vivo. , 2003, The Journal of investigative dermatology.

[2]  I. Frieden,et al.  Hemangiomas of infancy. , 2003, Journal of the American Academy of Dermatology.

[3]  M. Mihm,et al.  Infantile hemangioma: clinical resolution with 5% imiquimod cream. , 2002, Archives of dermatology.

[4]  M. Marini.  Imiquimod 5% cream: a topical immune response modifier , 2002, International journal of dermatology.

[5]  Richard L. Miller.  Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors , 2002, International journal of dermatology.

[6]  M. Dahl,et al.  Imiquimod: an immune response modifier. , 2000, Journal of the American Academy of Dermatology.

[7]  D. Sauder,et al.  Immunomodulatory and pharmacologic properties of imiquimod. , 2000, Journal of the American Academy of Dermatology.

[8]  R. Miller,et al.  Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. , 2000, The Journal of investigative dermatology.

[9]  L. Carmant,et al.  Toxicity profile of interferon alfa-2b in children: A prospective evaluation. , 1999, The Journal of pediatrics.

[10]  J. Folkman,et al.  Successful treatment of infantile hemangiomas with interferon-α-2b , 1997 .

[11]  A. H. Jacobs.  Strawberry hemangiomas; the natural history of the untreated lesion. , 1957, California medicine.